Prevalence of Risk Factors of Thromboembolic Complications in Women after Major Joint Arthroplasty in the Republic of Sakha (Yakutia)

Gennady A. Palshin, Stepan S. Pavlov, Mikhail M. Vinokurov, Natalia I. Douglas, Rosa D. Philippova, Valery E. Volovik, Anton A. Yakovlev, Anatoly N. Komissarov, Maria Yu. Markovchina

 
International Journal of Biomedicine. 2018;8(4):333-336.   
DOI: 10.21103/Article8(4)_OA13
Originally published December 15, 2018  

Abstract: 

The aim of this study was to assess the risk factors for thromboembolic complications after total arthroplasty of large joints in women in Yakutia conditions to optimize the management tactics of this category of patients. The average age of women was 59.98±11.56 years in the age range from 50 to 70 years. In order to validate the study, women were divided into 2 groups. The main group consisted of 284 women undergoing total knee arthroplasty (Group 1). The comparison group included 147 women undergoing total hip arthoplasty (Group 2). The study demonstrated that hypertension was more common in patients of Group 1 than in patients of Group 2. However, the incidence of coronary heart disease and heart rhythm disorder was detected most frequently in patients with total hip arthroplasty. Obesity, thrombosis of the veins of the lower extremities, and liver disease were detected with almost the same frequency in women with total knee arthroplasty and those with total hip arthroplasty. The frequency of occurrence of complications depending on the risk factors for thromboembolic complications and the type of surgical treatment of the joint was equal in the two groups of studied patients.

Keywords: 
thromboembolic complications • women • endoprosthetics • large joints
References: 
  1. Abeltsev V. P. Endoprosthetics of the hip joint at dysplastic coxatrosis (optimal treatment methods). Abstract of ScD Thesis. Moscow; 2004. [in Russian].
  2. Shapovalov VM, Tikhilov PM. Total hip arthroplasty. In: The state and prospects of development of military traumatology and orthopedics: SPb., 1999;248:549-557.
  3. Torchia ME, Klassen RA, Bianco AJ. Total hip arthroplasty with cement in patients less than twenty years old. Long-term results. J Bone Joint Surg Am. 1996;78(7):995-1003. PubMed
  4. Tikhilov PM, Shapovalov VM. Guide to hip arthroplasty. SPb.: RNIITO n.a. RR Vreden; 2008.
  5. Keggi KJ, Huo MH, Zatorski LE. Anterior approach to total hip replacement: surgical technique and clinical results of our first one thousand cases using non-cemented prostheses. Yale J Biol Med. 1993;66(3):243-56. PubMed
  6. Kopenkin SS. Prevention of venous thromboembolic complications in orthopedic surgery: new opportunities. N.N. Priorov Journal of Traumatology and Orthopedics; 2010;(1):35-39.
  7. Sheth NP, Lieberman JR, Della Valle CJ. DVT prophylaxis in total joint reconstruction.Orthop Clin North Am. 2010;41(2):273-80. doi: 10.1016/j.ocl.2010.02.001. PubMed
  8. Lieberman JR, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2005;87(9):2097-112. PubMed
  9. Pedersen AB, Mehnert F, Sorensen HT, Emmeluth C, Overgaard S, Johnsen SP. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice. Bone Joint J. 2014;96-B(4):479-85. doi: 10.1302/0301-620X.96B4.33209. PubMed
  10. Nikolenko VK, Buryachenko BP, Maksimov BI. Features of modern surgical treatment of bilateral coxarthrosis. N.N. Priorov Journal of Traumatology and Orthopedics; 2006;(4):34-41.
  11. Won MH, Lee GW, Lee TJ, Moon KH. Prevalence and risk factors of thromboembolism after joint arthroplasty without chemical thromboprophylaxis in an Asian population. J Arthroplasty. 2011;26(7):1106-11. doi: 10.1016/j.arth.2010.11.005. PubMed
  12. Zhang ZH, Shen B, Yang J, Zhou ZK, Kang PD, Pei FX. Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years. BMC Musculoskelet Disord. 2015;16:24. doi: 10.1186/s12891-015-0470-0. PubMed
  13. Sweetland S, Green J, Liu B, Berrington de González A, Canonico M, Reeves G, Beral V; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583. doi: 10.1136/bmj.b4583. PubMed
  14. Feng B, Lin J, Jin J, Qian WW, Wang W, Weng XS. Thirty-day Postoperative Complications following Primary Total Knee Arthroplasty: A Retrospective Study of Incidence and Risk Factors at a Single Center in China. Chin Med J (Engl). 2017;130(21):2551-2556. doi: 10.4103/0366-6999.213071. PubMed
  15. Plante S, Belzile EL, Fréchette D, Lefebvre J1. Analysis of contributing factors influencing thromboembolic events after total knee arthroplasty. Can J Surg. 2017;60(1):30-36. PubMed
  16. Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011 Dec;70(12):2082-8. doi: 10.1136/ard.2010.148726. Epub 2011 Oct 21. PubMed
  17. Memtsoudis SG, Ma Y, González Della Valle A, Mazumdar M, Gaber-Baylis LK, MacKenzie CR, Sculco TP. Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology. 2009;111(6):1206-16. doi: 10.1097/ALN.0b013e3181bfab7d. PubMed
  18. Memtsoudis SG, Della Valle AG, Besculides MC, Esposito M, Koulouvaris P, Salvati EA. Risk factors for perioperative mortality after lower extremity arthroplasty: a population-based study of 6,901,324 patient discharges. J Arthroplasty. 2010;25(1):19-26. doi: 10.1016/j.arth.2008.11.010. PubMed
  19. Machlus KR, Aleman MM, Wolberg AS. Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arterioscler Thromb Vasc Biol. 2011;31(3):476-8. doi: 10.1161/ATVBAHA.111.223008. PubMed
  20. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92(12):2156–64. doi: 10.2106/JBJS.I.00882. PubMed
  21. Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011;70(12):2082–8. doi: 10.1136/ard.2010.148726. PubMed
  22. Dua A, Neiva S, Sutherland A. Does previous varicose vein surgery alter deep vein thrombosis risk after lower limb arthroplasty? Orthop Surg. 2012;4(4):222–6. doi: 10.1111/os.12003. PubMed
  23. Zhang ZH, Shen B, Yang J, Zhou ZK, Kang PD, Pei FX. Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years. BMC Musculoskelet Disord. 2015;16:24. doi: 10.1186/s12891-015-0470-0. PubMed

Download Article
Received October 10, 2018.
Accepted November 1, 2018.
©2018 International Medical Research and Development Corporation.